Ono Pharmaceutical Co Ltd
OTC:OPHLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ono Pharmaceutical Co Ltd
OTC:OPHLY
|
JP |
|
K
|
Kikkoman Corp
DUS:KIK
|
JP |
|
G
|
Gladstone Capital Corp
F:1G7
|
US |
|
Allied Gold Corp
F:A240
|
CA |
Wall St Price Targets
OPHLY Price Targets Summary
Ono Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
OPHLY is 5.44 USD with a low forecast of 4.19 USD and a high forecast of 7.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OPHLY's stock price target?
Price Target
5.44
USD
According to Wall Street analysts, the average 1-year price target for
OPHLY is 5.44 USD with a low forecast of 4.19 USD and a high forecast of 7.15 USD.
What is the Revenue forecast for Ono Pharmaceutical Co Ltd?
Projected CAGR
-4%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is -4%.
What is the Gross Profit forecast for Ono Pharmaceutical Co Ltd?
Projected CAGR
-4%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 2 years is -4%.
What is the Operating Income forecast for Ono Pharmaceutical Co Ltd?
Projected CAGR
30%
Over the last 14 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 1 year is 30%.
What is the Pre-Tax Income forecast for Ono Pharmaceutical Co Ltd?
Projected CAGR
-6%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 2 years is -6%.
What is the Net Income forecast for Ono Pharmaceutical Co Ltd?
Projected CAGR
-6%
Over the last 14 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 2 years is -6%.